Cipta Selera Murni Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Cipta Selera Murni Tbk. trades at Rp75 (market cap 62.84B, 15.69M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 4.9× Cipta Selera Murni Tbk.'s market cap, and Cipta Selera Murni Tbk. is more actively traded (15.69M versus 963.6K). Which is the better fit depends on your goals.
| CSMI | DGNS | |
|---|---|---|
Market Cap | 62.84B | 310.75B |
Volume | 15.69M | 963.6K |
Lot | 156.89K | 9.64K |
Turnover | 1.18B | 217.67M |
Average Price | 75.51 | 225.89 |
Value | 1.18B | 217.67M |
Indicative Equilibrium Price | 75 | 226 |
Indicative Equilibrium Volume | 1K | 1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Selera Murni Tbk (Company) was established based on Notarial Deed No. 167 dated July 25,1983 of Winanto Wiryomartani, S.H., in Jakarta.
Read more on CSMI →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →